PMA device
IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
Medtronic Vascular, Inc. · Drug-Coated Peripheral Transluminal Angioplasty Catheter (PRC, Class III) · First FDA decision Nov 21, 2019, newest Apr 23, 2024Kidney failure and dialysisPeripheral artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
2
Naming "IN.PACT AV Paclitaxel-Coated"
MAUDE reports
0
Brand "IN.PACT AV Paclitaxel-Coated", since 2015
PubMed studies
0
Mentioning "IN.PACT AV Paclitaxel-Coated"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
P190008-S028 · Decided Apr 23, 2024 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
P190008-S025 · Decided Sep 14, 2023 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
- IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon CatheterPMA supplement
P190008-S018 · Decided Mar 4, 2022 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
3 more FDA decisions with a free account
Older decisions: P190008-S001, P190008
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal ArteriesNational analysisReview closedCAG-00085R4Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
- Percutaneous Transluminal Angioplasty (PTA)National determinationOn the books20.7Updated May 14, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "IN.PACT AV Paclitaxel-Coated", any status and sponsor, newest update first.
- IN.PACT™ AV Access IDE StudyPivotal-lookingCompleted
Medtronic EndovascularPublic (MDT)
NCT03041467 · 330 participants · Start Apr 25, 2017 · Primary completion Dec 6, 2018
Device: IN.PACT AV DCB; Standard Balloon Angioplasty · For: Arteriovenous Fistula Stenosis; Arteriovenous Fistula Occlusion; Arteriovenous Fistula and 1 more
Sites: Birmingham, Alabama; Tempe, Arizona; Sacramento, California · 29 sites in all
- Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)Pivotal-lookingCompleted
Shockwave Medical, Inc.Not on our public-company list
NCT02923193 · 306 participants · Start Feb 22, 2017 · Primary completion May 12, 2020
Device: Shockwave Lithoplasty® Peripheral Lithoplasty System · For: Peripheral Arterial Disease
Sites: Little Rock, Arkansas; Palo Alto, California; Aurora, Colorado · 54 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "IN.PACT AV Paclitaxel-Coated", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PRC
543 reports: 107 malfunction, 427 injury, 9 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic IN.PACT AV, Paclitaxel-coated PTA Balloon Catheter, REF: IAV06008008P, Sterile EO, Rx OnlyOpen, Classified
Z-1043-2022 · Started Mar 23, 2022
Reason given: Packaging for Balloon Catheters may be damaged resulting in loss of sterility.
Cause as FDA categorized it: Packaging process control · Device type: Drug-Coated Peripheral Transluminal Angioplasty Catheter (PRC)
Published research
The most relevant PubMed records for "IN.PACT AV Paclitaxel-Coated"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PRC.
- LUTONIX 035 Drug Coated Balloon PTA Catheter, Model 9010Lutonix · PMA 2019
- Lutonix Drug Coated Balloon PTA CatheterLutonix · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.